Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute

Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. https://www.dana-farber.org/multiple-...